Treatment of chronic hepatitis C;Behandling af kronisk hepatitis C

Ugeskrift for Laeger

Volumn 168, Issue 12, 2006, Pages 1221-

  Weis, Nina M ^a   Christensen, Peer Brehm ^b   Laursen, Alex Lund ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

GENOTYPE; HEPATITIS C VIRUS; IMMUNOMODULATION; SHORT SURVEY;

ANTIVIRAL AGENTS; GENE THERAPY; HEPATITIS C, CHRONIC; HUMANS; IMMUNOLOGIC FACTORS; VIRAL HEPATITIS VACCINES;

EID: 33645796216     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (3)

1. Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science 2005;309:623-6.
2. Hinrichsen H, Benhamou Y, Wedemeyer H et al. Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients. Gastroenterology 2004;127:1347-55
3. Li K, Foy E, Ferreon JC, Ikeda M et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 2005;102:2992-7.